NeuroOne® to Report Third Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on August 14GlobeNewsWire • 08/08/23
NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common StockGlobeNewsWire • 07/24/23
NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode in Robotic NeurosurgeryGlobeNewsWire • 05/17/23
NeuroOne Medical Technologies Corporation (NMTC) Q2 2023 Earnings Call TranscriptSeeking Alpha • 05/13/23
NeuroOne® Reports Second Quarter Fiscal Year 2023 Financial Results and Provides Corporate UpdateGlobeNewsWire • 05/11/23
NeuroOne® to Report Second Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on May 11GlobeNewsWire • 05/11/23
NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode Performed at Mayo ClinicGlobeNewsWire • 05/10/23
NeuroOne® Successfully Completes Initial Animal Implant of Novel Thin Film Paddle Lead for Spinal Cord StimulationPRNewsWire • 03/16/23
NeuroOne® Awarded U.S. Patent Covering Novel and Proprietary Thin Film Electrode PlatformPRNewsWire • 03/07/23
NeuroOne Medical Technologies Corporation (NMTC) Q1 2023 Earnings Call TranscriptSeeking Alpha • 02/14/23
NeuroOne® Reports First Quarter Fiscal Year 2023 Financial Results and Provides Corporate UpdatePRNewsWire • 02/14/23
NeuroOne® to Report First Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on February 14PRNewsWire • 02/09/23
NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2022 Financial ResultsPRNewsWire • 12/22/22
NeuroOne Medical Technologies Corporation (NMTC) Q4 2022 Earnings Call TranscriptSeeking Alpha • 12/13/22
NeuroOne® to Report Fourth Quarter and Fiscal Year 2022 Financial Results and Provide Corporate Update on December 13PRNewsWire • 12/08/22
NeuroOne® Successfully Completes Feasibility Study with its OneRF™ Ablation SystemPRNewsWire • 12/06/22
NeuroOne® Ships Initial Zimmer Biomet Order for its Evo® sEEG System for Less than 30 Day UsePRNewsWire • 11/30/22